Literature DB >> 9521467

DNA copy number changes in alveolar soft part sarcoma: a comparative genomic hybridization study.

S Kiuru-Kuhlefelt1, W El-Rifai, M Sarlomo-Rikala, S Knuutila, M Miettinen.   

Abstract

Alveolar soft part sarcoma (ASPS) is a rare, histologically distinctive soft tissue sarcoma typically occurring in children and young adults. Although the tumor often shows focal expression of muscle markers, its relationship with rhabdomyosarcoma is not established. The genetic background of ASPS is poorly understood. This study was undertaken to analyze the DNA copy number changes in 13 cases of ASPS using comparative genomic hybridization (CGH) on formaldehyde-fixed, paraffin-embedded tissue sections. Four ASPS cases showed DNA copy number changes. Gains were more common than losses. Gains observed in more than one case included 1q, 8q, 12q and 16p. Although these findings do not show consistent DNA copy number changes in ASPS, they give preliminary clues to genomic areas that might be important in the pathogenesis of ASPS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521467

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  3 in total

1.  High-resolution array CGH and gene expression profiling of alveolar soft part sarcoma.

Authors:  Shamini Selvarajah; Saumyadipta Pyne; Eleanor Chen; Ramakrishna Sompallae; Azra H Ligon; Gunnlaugur P Nielsen; Glenn Dranoff; Edward Stack; Massimo Loda; Richard Flavin
Journal:  Clin Cancer Res       Date:  2014-02-03       Impact factor: 12.531

Review 2.  Comparative genomic hybridization and chromosomal instability in solid tumours.

Authors:  P H Rooney; G I Murray; D A Stevenson; N E Haites; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

3.  Transgenic CHD1L expression in mouse induces spontaneous tumors.

Authors:  Muhan Chen; Jian-dong Huang; Liang Hu; Bo-jian Zheng; Leilei Chen; Sze Lan Tsang; Xin-yuan Guan
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.